KerrC, HolahanT, MilchR. The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: a case series. J Palliat Med, 2011; 14:1–4.
2.
McQuayH. Antidepressants and chronic pain. Br Med J, 1997; 314:763–764.
3.
KunzR, OxmanAD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ, 1998; 317:1185–1190.
4.
AbernethyAP, McDonaldCF, FrithPA, ClarkK, HerndonJE, MarcelloJ, YoungIH, BullJ, WilcockA, BoothS, WheelerJL, TulskyJA, CrockettAJ, CurrowDC. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: A double-blind randomized controlled trial (NCT00327873)Lancet, 2010; 376:784–793.
5.
CurrowDC, Shelby-JamesTM, AgarM, PlummerJ, RowettD, GlareP, SpruytO, HardyJ. Planning phase III multi-site clinical trials in palliative care: The role of consecutive cohort audits to identify potential participant populations. J Support Care Cancer, 2010; 18:1571–1578.
